Incremental hemodialysis, a valuable option for the frail elderly patient.

Elderly patients End-stage renal disease Frailty Incremental hemodialysis Residual kidney function Urea kinetic modeling

Journal

Journal of nephrology
ISSN: 1724-6059
Titre abrégé: J Nephrol
Pays: Italy
ID NLM: 9012268

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 28 01 2019
accepted: 13 04 2019
pubmed: 21 4 2019
medline: 4 9 2020
entrez: 21 4 2019
Statut: ppublish

Résumé

Management of older people on dialysis requires focus on the wider aspects of aging as well as dialysis. Recognition and assessment of frailty is vital in changing our approach in elderly patients. Current guidelines in dialysis have a limited evidence base across all age group, but particularly the elderly. We need to focus on new priorities of care when we design guidelines "for people not diseases". Patient-centered goal-directed therapy, arising from shared decision-making between physician and patient, should allow adaption of the dialysis regime. Hemodialysis (HD) in the older age group can be complicated by intradialytic hypotension, prolonged time to recovery, and access-related problems. There is increasing evidence relating to the harm associated with the delivery of standard thrice-weekly HD. Incremental HD has a lower burden of treatment. There appears to be no adverse clinical effects during the first years of dialysis in presence of a significant residual kidney function. The advantages of incremental HD might be particularly important for elderly patients with short life expectancy. There is a need for more research into specific topics such as the assessment of the course of frailty with progression of chronic kidney disease and after dialysis initiation, the choice of dialysis modality impacting on the trajectory of frailty, the timing of dialysis initiation impacting on frailty or on other outcomes. In conclusion, understanding each individual's goals of care in the context of his or her life experience is particularly important in the elderly, when overall life expectancy is relatively short, and life experience or quality of life may be the priority.

Identifiants

pubmed: 31004284
doi: 10.1007/s40620-019-00611-4
pii: 10.1007/s40620-019-00611-4
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

741-750

Références

Nephrol Dial Transplant. 1999 Jan;14(1):121-4
pubmed: 10052490
Am J Kidney Dis. 2001 Jan;37(1 Suppl 1):S7-S64
pubmed: 11229967
Nephrol Dial Transplant. 2001 Nov;16(11):2207-13
pubmed: 11682669
Kidney Int. 2002 Aug;62(2):639-47
pubmed: 12110029
N Engl J Med. 2002 Dec 19;347(25):2010-9
pubmed: 12490682
JAMA. 2003 Mar 19;289(11):1371-3
pubmed: 12636453
Sci Aging Knowledge Environ. 2005 Aug 03;2005(31):pe24
pubmed: 16079413
Am J Kidney Dis. 2006 Jul;48 Suppl 1:S2-90
pubmed: 16813990
Blood Purif. 2007;25(3):295-302
pubmed: 17622712
J Am Soc Nephrol. 2007 Oct;18(10):2758-65
pubmed: 17855638
J Am Soc Nephrol. 2007 Nov;18(11):2960-7
pubmed: 17942958
JAMA. 2007 Nov 7;298(17):2038-47
pubmed: 17986697
Clin J Am Soc Nephrol. 2008 Jan;3(1):19-26
pubmed: 18003765
BMC Public Health. 2008 Apr 11;8:117
pubmed: 18405348
Kidney Int. 2008 Aug;74(3):262-4
pubmed: 18626495
Nephrology (Carlton). 2009 Feb;14(1):59-64
pubmed: 19019171
Nephrol Dial Transplant. 2009 Aug;24(8):2502-10
pubmed: 19240122
J Am Soc Nephrol. 2009 Jun;20(6):1199-209
pubmed: 19470680
N Engl J Med. 2009 Oct 15;361(16):1539-47
pubmed: 19828531
N Engl J Med. 2009 Oct 15;361(16):1612-3
pubmed: 19828543
Am J Kidney Dis. 2010 Jan;55(1):31-41
pubmed: 19932544
J Nephrol. 2009 Nov-Dec;22(6):794-9
pubmed: 19967659
N Engl J Med. 2010 Aug 12;363(7):609-19
pubmed: 20581422
Am J Kidney Dis. 2010 Aug;56(2):348-58
pubmed: 20605303
Clin J Am Soc Nephrol. 2011 Feb;6(2):290-6
pubmed: 21030575
Kidney Int. 2011 Jul;80(1):93-104
pubmed: 21289597
Nephrol Dial Transplant. 2011 Sep;26(9):2978-83
pubmed: 21317411
Semin Dial. 2011 Sep-Oct;24(5):487-94
pubmed: 21999737
Nephrol Dial Transplant. 2012 Apr;27(4):1284-7
pubmed: 22273667
Clin J Am Soc Nephrol. 2012 Jun;7(6):1039-46
pubmed: 22516288
Arch Intern Med. 2012 Jul 23;172(14):1071-7
pubmed: 22733312
Rejuvenation Res. 2012 Dec;15(6):545-52
pubmed: 22950422
J Nephrol. 2012;25 Suppl 19:S85-9
pubmed: 22972669
J Nephrol. 2013 Jul-Aug;26(4):763-70
pubmed: 23147685
Eur J Intern Med. 2013 Jan;24(1):40-4
pubmed: 23186603
Kidney Int. 2013 May;83(5):949-58
pubmed: 23344474
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
Am J Kidney Dis. 2013 Aug;62(2):245-52
pubmed: 23566637
Toxicology. 2013 Jul 5;309:39-51
pubmed: 23603429
CMAJ. 2013 Jun 11;185(9):E417-23
pubmed: 23649413
Clin J Am Soc Nephrol. 2013 Aug;8(8):1421-8
pubmed: 23788617
Semin Dial. 2013 Nov-Dec;26(6):690-6
pubmed: 24004376
Semin Dial. 2013 Nov-Dec;26(6):720-7
pubmed: 24016197
BMC Nephrol. 2013 Oct 22;14:228
pubmed: 24148266
J Am Soc Nephrol. 2014 Jan;25(1):143-9
pubmed: 24262795
Am J Kidney Dis. 2014 Jul;64(1):86-94
pubmed: 24529994
Am J Kidney Dis. 2014 Sep;64(3):434-42
pubmed: 24679895
Semin Nephrol. 2014 Mar;34(2):191-208
pubmed: 24780473
Nephrol Dial Transplant. 2014 Sep;29(9):1618-20
pubmed: 24782534
Am J Kidney Dis. 2014 Aug;64(2):181-6
pubmed: 24840669
Clin J Am Soc Nephrol. 2015 Mar 6;10(3):363-71
pubmed: 25710804
Nephrol Dial Transplant. 2015 Oct;30(10):1639-48
pubmed: 26038351
Nephrol Dial Transplant. 2015 Oct;30(10):1602-4
pubmed: 26163880
Int Urol Nephrol. 2015 Nov;47(11):1801-7
pubmed: 26411428
Am J Kidney Dis. 2015 Nov;66(5):884-930
pubmed: 26498416
BMC Nephrol. 2015 Dec 01;16:193
pubmed: 26620131
Adv Chronic Kidney Dis. 2016 Jan;23(1):51-6
pubmed: 26709063
Am J Kidney Dis. 2016 Aug;68(2):256-265
pubmed: 26867814
Expert Rev Clin Pharmacol. 2016;9(5):727-37
pubmed: 26885869
Am J Kidney Dis. 2016 Sep;68(3):444-54
pubmed: 26968042
Kidney Int. 2016 Aug;90(2):262-271
pubmed: 27182000
Am J Kidney Dis. 2016 Aug;68(2):180-183
pubmed: 27477358
Semin Dial. 2016 Nov;29(6):476-480
pubmed: 27561174
J Nephrol. 2016 Dec;29(6):871-879
pubmed: 27582136
Nephrol Dial Transplant. 2017 Jan 1;32(1):182-190
pubmed: 27742823
Kidney Int. 2017 Feb;91(2):294-303
pubmed: 27773426
Nephrol Dial Transplant. 2016 Nov;31(suppl 2):ii1-ii66
pubmed: 27807144
Clin J Am Soc Nephrol. 2017 May 8;12(5):854-863
pubmed: 28031417
Int Urol Nephrol. 2017 Nov;49(11):1989-1997
pubmed: 28229311
J Nephrol. 2017 Aug;30(4):521-529
pubmed: 28337715
J Nephrol. 2017 Aug;30(4):593-599
pubmed: 28500518
Nephrol Dial Transplant. 2018 Jul 1;33(7):1103-1109
pubmed: 28992335
Nephrol Dial Transplant. 2018 Jun 1;33(6):1046-1053
pubmed: 29315407
Nephrol Dial Transplant. 2018 May 1;33(5):742-750
pubmed: 29566211
J Am Soc Nephrol. 2018 Jul;29(7):1992-1999
pubmed: 29728422
Semin Dial. 2018 Nov;31(6):607-611
pubmed: 30239040
Nephrol Dial Transplant. 2018 Oct 17;:null
pubmed: 30339192
Clin Kidney J. 2018 Dec;11(6):853-856
pubmed: 30524721
J Nephrol. 2019 Oct;32(5):823-836
pubmed: 30604150
BMC Nephrol. 2019 Jan 9;20(1):8
pubmed: 30626347
Nephrol Dial Transplant. 2019 Feb 25;:null
pubmed: 30805639
Hemodial Int. 2019 Jul;23(3):288-296
pubmed: 30860667
Nephrol Dial Transplant. 2019 Mar 15;:null
pubmed: 30879076
Kidney Int. 1985 Sep;28(3):526-34
pubmed: 3934452
N Engl J Med. 1981 Nov 12;305(20):1176-81
pubmed: 7027040
Nephrol Dial Transplant. 1995 Dec;10(12):2274-80
pubmed: 8808225
Nephrol Dial Transplant. 1996 Aug;11(8):1574-81
pubmed: 8856214

Auteurs

Carlo Basile (C)

Clinical Research Branch, Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy. basile.miulli@libero.it.
Associazione Nefrologica Gabriella Sebastio, Martina Franca, Italy. basile.miulli@libero.it.

Francesco Gaetano Casino (FG)

Clinical Research Branch, Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy.
Dialysis Centre SM2, Potenza, Italy.

Filippo Aucella (F)

Department of Nephrology and Dialysis, Research Hospital "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH